cyclosporine and Glaucoma, Suspect

cyclosporine has been researched along with Glaucoma, Suspect in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
An, JH; Cho, SY; Jun, JH; Kim, JG; Lee, CE; Shim, KY1
Ju, WK; Kim, KY; Kim, SY; Shim, MS; Weinreb, RN; Wheeler, LA1
Htoon, HM; Huang, OS; Mehta, JS; Tan, DT; Wong, TT1
Al-Agha, S; Cavanagh, HD; Chung, MS; El-Agha, MS; Pepose, JS1
Acheampong, A; D'Aversa, G; Donnenfeld, ED; Kanellopoulos, AJ; Perry, HD; Sforza, PD; Stern, M; Wallerstein, A1

Trials

1 trial(s) available for cyclosporine and Glaucoma, Suspect

ArticleYear
Efficacy of Topical 0.05% Cyclosporine A for Ocular Surface Disease Related to Topical Anti-Glaucoma Medications.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2023, Volume: 39, Issue:6

    Topics: Antiglaucoma Agents; Cyclosporine; Humans; Matrix Metalloproteinase 9; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Reproducibility of Results; Tears

2023

Other Studies

4 other study(ies) available for cyclosporine and Glaucoma, Suspect

ArticleYear
Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury.
    Cell death & disease, 2014, Mar-06, Volume: 5

    Topics: Animals; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Caspase 3; Cell Survival; Cyclophilins; Cyclosporine; Cytoprotection; Disease Models, Animal; DNA-Binding Proteins; DNA, Mitochondrial; Female; High Mobility Group Proteins; Intraocular Pressure; Ischemia; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neuroprotective Agents; Ocular Hypertension; Peptidyl-Prolyl Isomerase F; Phosphorylation; Retinal Diseases; Retinal Ganglion Cells; Time Factors

2014
Incidence and Risk Factors of Elevated Intraocular Pressure Following Deep Anterior Lamellar Keratoplasty.
    American journal of ophthalmology, 2016, Volume: 170

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Corneal Transplantation; Cyclosporine; Dexamethasone; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans; Immunosuppressive Agents; Incidence; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Olopatadine Hydrochloride; Prednisolone; Retrospective Studies; Risk Factors; Tonometry, Ocular

2016
Confocal microscopic findings in a case of delayed-onset bilateral diffuse lamellar keratitis after laser in situ keratomileusis.
    Journal of cataract and refractive surgery, 2002, Volume: 28, Issue:8

    Topics: Adult; Cornea; Cyclosporine; Female; Humans; Keratitis; Keratomileusis, Laser In Situ; Microscopy, Confocal; Ocular Hypertension; Prednisolone; Surgical Flaps

2002
Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber.
    The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc, 1998, Volume: 24, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Chromatography, High Pressure Liquid; Cornea; Cyclosporine; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Keratoplasty, Penetrating; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies

1998